Increased risk of major adverse cardiac events following the onset of acute exacerbations of COPD

被引:39
|
作者
Reilev, Mette [1 ,2 ]
Pottegard, Anton [1 ]
Lykkegaard, Jesper [2 ]
Sondergaard, Jens [2 ]
Ingebrigtsen, Truls S. [3 ,4 ]
Hallas, Jesper [1 ]
机构
[1] Univ Southern Denmark, Dept Publ Hlth, Clin Pharmacol & Pharm, JB Winslows Vej 19, DK-5000 Odense, Denmark
[2] Univ Southern Denmark, Dept Publ Hlth, Res Unit Gen Practice, Odense, Denmark
[3] Copenhagen Univ Hosp, Hvidovre Hosp, Dept Resp Med, Copenhagen, Denmark
[4] Copenhagen Univ Hosp, Amager Hosp, Dept Resp Med, Copenhagen, Denmark
关键词
acute chronic obstructive pulmonary disease exacerbations; chronic obstructive pulmonary disease; epidemiological studies; myocardial infarction; stroke; OBSTRUCTIVE PULMONARY-DISEASE; MYOCARDIAL-INFARCTION; MORTALITY; GLUCOCORTICOIDS; FIBRINOGEN; STROKE;
D O I
10.1111/resp.13620
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background and objective Acute exacerbations in chronic obstructive pulmonary disease (COPD) may trigger major adverse cardiac events (MACE). We aimed to determine whether the risk of having MACE was transiently increased following the onset of an acute COPD exacerbation. Methods We conducted a nationwide, register-based study from 1997 to 2014 comprising individuals with an acute COPD exacerbation followed by a MACE (acute myocardial infarction (MI), stroke or cardiovascular death). Using the case-crossover design, we estimated odds ratios (OR) for the association between acute exacerbations of COPD and MACE as well as for single outcomes (acute MI, stroke and cardiovascular death), different levels of severity of exacerbations and within patient subgroups. Results We identified 118 807 cases with a MACE preceded by an exacerbation. Overall, the risk of MACE increased almost fourfold following the onset of an acute exacerbation compared to periods without exacerbations in the same individuals (OR: 3.70; 95% CI: 3.60-3.80). The associations were consistent for single outcomes (acute MI, OR: 3.57; cardiovascular death, OR: 4.33; and stroke, OR: 2.78) and particularly strong associations were demonstrated for severe exacerbations (OR: 5.92) and the oldest individuals (OR: 4.18). Conclusion The risk of MACE increased substantially following the onset of an acute exacerbation. This highlights that prevention of cardiac events is an important goal in the management of COPD. Attention should be paid to detecting cardiovascular disease following acute COPD exacerbations.
引用
收藏
页码:1183 / 1190
页数:8
相关论文
共 50 条
  • [1] Myotrophin predicts risk of major adverse cardiac events following acute coronary syndromes
    Khan, S.
    Kelly, D.
    Quinn, P.
    Ng, L.
    [J]. HEART, 2006, 92 : A48 - A49
  • [2] Effects of Aclidinium Bromide on Major Adverse Cardiovascular Events and COPD Exacerbations in Patients with COPD and Cardiovascular Risk Factors
    Wise, R. A.
    Scirica, B. M.
    Schoenfeld, D. A.
    Daoud, S. Z.
    Roman, J.
    Reisner, C.
    Gil, E. Garcia
    Chapman, K. R.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [3] Increased risk of severe cardiovascular events following exacerbations of COPD: a multidatabase cohort study
    Vogelmeier, Claus
    Simons, Sami
    Garbe, Edeltraut
    Sin, Don
    Hawkins, Nathaniel
    Manito, Nicolas
    Santos, Salud
    Polinder, Karin
    Lobier, Muriel
    Ekwaru, Paul
    Kossack, Nils
    Hernandez, Ignacio
    Mullerova, Hana
    Randhawa, Arsh
    Van Burk, Lindy
    Sanchez-Covisa, Joaquin
    Rhodes, Kirsty
    Nordon, Clementine
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [4] COPD Exacerbations and Risk of Major Adverse Cardiac Events: A Danish Nationwide Register-Based Case-Crossover Study
    Reilev, Mette
    Pottegard, Anton
    Lykkegaard, Jesper
    Sondergaard, Jens
    Ingebrigtsen, Truls Sylvan
    Hallas, Jesper
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 384 - 385
  • [5] Symptoms irregularity and increased risk of COPD acute exacerbations
    Duarte-de-Araujo, A.
    Teixeira, P.
    Hespanhol, V.
    Correia-de-Sousa, J.
    [J]. PULMONOLOGY, 2018, 24 (03): : 196 - 197
  • [6] Pretransplant Cardiac Biomarkers and Risk of Major Adverse Cardiac Events Following Liver Transplantation
    Albeldawi, Mazen
    Gupta, Vedant
    Singh, Gurshawn
    Mehta, Paresh P.
    Lopez, Rocio
    Eghtesad, Bijan
    Marwick, Thomas
    Zein, Nizar N.
    [J]. GASTROENTEROLOGY, 2012, 142 (05) : S1004 - S1004
  • [8] Frailty Is Associated with an Increased Risk of Major Adverse Cardiac Events in Patients with Stable Claudication
    Schaller, Melinda S.
    Ramirez, Joel L.
    Gasper, Warren J.
    Zahner, Greg J.
    Hills, Nancy K.
    Grenon, S. Marlene
    [J]. ANNALS OF VASCULAR SURGERY, 2018, 50 : 38 - 45
  • [9] Risk of Nonlower Respiratory Serious Adverse Events Following COPD Exacerbations in the 4-year UPLIFT® Trial
    Halpin, David M. G.
    Decramer, Marc
    Celli, Bartolome
    Kesten, Steven
    Leimer, Inge
    Tashkin, Donald P.
    [J]. LUNG, 2011, 189 (04) : 261 - 268
  • [10] Risk of Nonlower Respiratory Serious Adverse Events Following COPD Exacerbations in the 4-year UPLIFT® Trial
    David M. G. Halpin
    Marc Decramer
    Bartolome Celli
    Steven Kesten
    Inge Leimer
    Donald P. Tashkin
    [J]. Lung, 2011, 189 : 261 - 268